Celtro To Introduce Latest Innovations At Electronica 2024

Celtro was founded in 2019, they have been working on the development of innovative solutions for energy harvesting and electrical stimulation of medical devices directly interfacing with biological tissues.

Their aim is to redesign medical implants by creating battery-free devices that can operate autonomously within the human body. Celtro has expanded operations from feasibility studies and patent filings into prototype devices closer to being market ready. These inventions are part of the bigger vision in terms of providing sustainable implantable technology for the monitoring and support of vital organ functions.

During the upcoming Electronica 2024 trade show at Messe Munich, Celtro's Managing Director Dr.-Ing. Gerd Teepe will introduce their latest innovations in bioelectric energy harvesting.

His talk will explain how Celtro's systems can capture electrochemical potentials from cells, therefore eliminating the need for batteries in some medical devices such as pacemakers. With the increase in the number of connections between tissue and device, Celtro's technology improves reliability and energy efficiency—clearly a huge step toward more resilient and accessible health care solutions for patients dependent on medical implants.